Tandem offers a variety of products designed to be easy to use and flexible enough to meet a broad variety of individual needs and lifestyles. Get to know how Control-IQ technology adjusts insulin delivery to help prevent highs and lows. t:slim X2 und t:simulator sind Marken von Tandem Diabetes Care, Inc. Dexcom, Dexcom G5 Mobile und Dexcom G6 sind entweder eingetragene Marken oder Marken von Dexcom, Inc. in den USA und/oder anderen Ländern. 38 % kleiner als MiniMed 640G und 670G und mindestens 28 % kleiner als MiniMed 530G, Animas Vibe und das Omnipod-System. Control-IQ technology gradually increases basal insulin with increasing CGM values Tandem Diabetes Care, Inc. TNDM recently announced the receipt of Health Canada’s approval for its t:slim X2 insulin pump with Control-IQ technology. : The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. Brown SA, Kovatchev BP, Raghinaru D, et al. Find the diabetes education materials you need to get your patients started today using Tandem insulin pumps, infusion sets, Control-IQ and Basal-IQ predictive technologies as well as our t:connect diabetes management system. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump : The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. 79th Scientific Sessions, American Diabetes Association, San Francisco, CA; June 9, 2019. References:1. Archivdaten. Tandem’s t:slim X2 Insulin Pump: Q&A The t:slim X2 is the same size and shape as the t:slim pump. In January 2020, I received an email from the Tandem Diabetes Care team that my t:slim X2 insulin pump was eligible for the Control-IQ update. Achten Sie immer auf Ihre Symptome, überwachen Sie aktiv Ihren Glukosespiegel und behandeln Sie ihn gemäß den Empfehlungen Ihres Arztes. Wenn das System mit einem kompatiblen interoperablen kontinuierlichen Glukosemonitor (iCGM) genutzt wird, kann die Basal-IQ™-Technologie die Insulinabgabe aufgrund der Werte des CGM-Sensors unterbrechen. Let's start with how the system works. Insulin pumps are a type of insulin delivery device that simulate the way the pancreas works by delivering small doses of insulin throughout the body. So I chose Basal IQ and I am now in the unique position of being able to choose between Basal IQ and Control IQ depending on which pump I am using. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. * In studies, the system was available 92% of the time.1. Tandem Diabetes Care today announced Health Canada approval of the t:slim X2™ insulin pump with Control-IQ™ technology. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump is indicated for use in individuals six years of age and greater. and will not share your information with any third-parties, except as noted in our. The t:slim X2 pump, Basal-IQ technology, and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin. Tandem describes Control-IQ as “an advanced hybrid closed-loop system that uses an algorithm to automatically adjust insulin in response to predicted glucose levels to help increase time in the American Diabetes Association-recommended target range (70-180 mg/dL).” BOXED WARNING: Control-IQ technology for the t:slim X2 pump should not be used by people under age 6, or who use less than 10 units of insulin… All form fields are required. The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. * Wenn die Blutzuckerwarnungen und CGM-Messwerte Ihres Dexcom G6 CGM Systems nicht Ihren Symptomen oder Erwartungen entsprechen, sollten Sie Ihre Entscheidungen zur Diabetesbehandlung mithilfe eines Blutzuckermessgeräts treffen. The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. Tandem’s Control-IQ, an automated insulin delivery system that uses Dexcom G6 CGM data to adjust basal insulin delivery and deliver automatic correction boluses, is poised to be the second hybrid closed loop system on the US market (after the MiniMed 670G). Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. The problem I have noticed is the loss of data from the G6 transmitter to the pump. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. By using the Dexcom G6, Control-IQ offers the many advantages of AID without fingersticks. From this screen, you can turn Control-IQ technology ON or OFF. Control-IQ technology will not function as intended unless all system components, including CGM, infusion sets and pump cartridges, are used as instructed. The pump is able … By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. The pump is able … By using this website you consent to our use of these cookies. In the National Institutes of Health-funded Diabetes Closed Loop Trial, Protocol 3, time in range* for We are taking the current COVID-19 pandemic very seriously and have taken steps to protect the health, safety and well-being of our customers, employees, and communities >>. t:slim X2 insulin pump ‡Software- und Funktionsupdates unterliegen behördlichen Genehmigungen und sind möglicherweise nicht in allen Regionen verfügbar. Health Canada has approved Tandem Diabetes Care's (NASDAQ:TNDM) t:slim X2 insulin pump with Control-IQ technology. Please note that in order to turn on Control-IQ technology, the following settings must be configured in your active Personal Profile: Carbs must be turned on and a Basal rate, Correction Factor, Carb Ratio, and Target BG must be defined. During troubleshooting with tandem technical support, the customer corrected the time and resumed insulin therapy. ahead and adjust insulin delivery accordingly, including delivery of It automatically resumes again when the sugar passes nadir and starts rising again.I’m happy to see this predictive feature. Tandem’s HCL system features the sleek Tandem t:slim tubed insulin pump with a full-color touch-screen display. It utilizes the sensor values from an integrated Dexcom G6 sensor to help reduce the frequency and duration of a hypoglycemic event (low blood sugar). 2019;381(18):1707-17. If you are a Tandem pump user, please contact Tandem. Control-IQ technology is an advanced hybrid closed-loop feature designed to help increase time in range (3.9-10 mmol/L) 1 … The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin. Control-IQ technology includes optional settings for Sleep and Exercise Activities that adjust treatment ranges to better match physiologic needs when active or sleeping.